Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin H Lok

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 13, 2023
Radiation Therapy in the Molecular Era of Lung Cancer: How Best to Integrate Targeted Therapeutics With Definitive Radiation Therapy for Epidermal Growth Factor Receptor-Mutant Unresectable Stage III Non-Small Cell Lung Cancer?Benjamin H Lok
Expert Review of Anticancer Therapy|August 29, 2024
PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probesTony Yu, Benjamin H Lok
Cancers|October 26, 2024
Strategies to Target Chemoradiotherapy Resistance in Small Cell Lung CancerTony Yu, Benjamin H Lok
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2019
Epigenetic targeting of DNA repair in lung cancerBenjamin H Lok, Charles M Rudin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2012
Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancementBenjamin H Lok, Simon N Powell
Journal of Thoracic Disease|November 19, 2020
PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approachesRanya Barayan, Xiaozhuo Ran, Benjamin H Lok
Genes|September 28, 2024
Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical ApplicationsJanice J N Li, Geoffrey Liu, Benjamin H Lok
Current Oncology (Toronto, Ont.)|January 22, 2024
Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and ApplicationsDanielle Benedict Sacdalan, Sami Ul Haq, Benjamin H Lok
Frontiers in Oncology|December 7, 2020
Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung CancerSonam Puri, Benjamin H Lok, Natasha Leighl, et al.
Seminars in Cancer Biology|August 2, 2022
Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside reviewJiaqi Xiong, Ranya Barayan, Alexander V Louie, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|August 13, 2023
Radiation Therapy in the Molecular Era of Lung Cancer: How Best to Integrate Targeted Therapeutics With Definitive Radiation Therapy for Epidermal Growth Factor Receptor-Mutant Unresectable Stage III Non-Small Cell Lung Cancer?Benjamin H Lok
Expert Review of Anticancer Therapy|August 29, 2024
PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probesTony Yu, Benjamin H Lok
Cancers|October 26, 2024
Strategies to Target Chemoradiotherapy Resistance in Small Cell Lung CancerTony Yu, Benjamin H Lok
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2019
Epigenetic targeting of DNA repair in lung cancerBenjamin H Lok, Charles M Rudin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2012
Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancementBenjamin H Lok, Simon N Powell
Journal of Thoracic Disease|November 19, 2020
PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approachesRanya Barayan, Xiaozhuo Ran, Benjamin H Lok
Genes|September 28, 2024
Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical ApplicationsJanice J N Li, Geoffrey Liu, Benjamin H Lok
Current Oncology (Toronto, Ont.)|January 22, 2024
Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and ApplicationsDanielle Benedict Sacdalan, Sami Ul Haq, Benjamin H Lok
Frontiers in Oncology|December 7, 2020
Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung CancerSonam Puri, Benjamin H Lok, Natasha Leighl, et al.
Seminars in Cancer Biology|August 2, 2022
Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside reviewJiaqi Xiong, Ranya Barayan, Alexander V Louie, et al.
Pageof 8